Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1071-1080 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|July 1, 1993
Interleukin-4 priming enhances a target for human complement-mediated cytotoxicity of CLLM S Czuczman, K Class, D A Scheinberg
Leukemia|June 1, 1994
Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromesM Flactif, J L Lai, C Preudhomme, et al.
Leukemia|June 1, 1994
Residual disease in B-cell chronic lymphocytic leukemia patients and prognostic valueB Lenormand, M Bizet, C Fruchart, et al.
Leukemia|June 1, 1994
Expression of GATA-1 mRNA in human myeloid leukemic cellsA Guerrasio, G Saglio, C Rosso, et al.
Leukemia|June 1, 1994
In vivo clonal evolution of pre-B to B-cell acute lymphoblastic leukemia in childhoodA Toren, G Kende, M Mandel, et al.
Leukemia|June 1, 1994
Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemiaA M Eardley, G Heller, R P Warrell
Leukemia|October 19, 2022
Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysisNicholas J Short, Chenqi Fu, Donald A Berry, et al.
Leukemia|December 1, 1993
Acute myeloid leukemia (AML) can be oligoclonalH M Schmetzer, H H Gerhartz
Leukemia|March 16, 2002
Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndromeH A Rossi, J O'Donnell, F Sarcinelli, et al.
Leukemia|March 16, 2002
The enhanced in vitro hematopoietic activity of leridistim, a chimeric dual G-CSF and IL-3 receptor agonistA L Abegg, L E Vickery, M E Bremer, et al.
Pageof 963

Showing results (1071-1080 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|July 1, 1993
Interleukin-4 priming enhances a target for human complement-mediated cytotoxicity of CLLM S Czuczman, K Class, D A Scheinberg
Leukemia|June 1, 1994
Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromesM Flactif, J L Lai, C Preudhomme, et al.
Leukemia|June 1, 1994
Residual disease in B-cell chronic lymphocytic leukemia patients and prognostic valueB Lenormand, M Bizet, C Fruchart, et al.
Leukemia|June 1, 1994
Expression of GATA-1 mRNA in human myeloid leukemic cellsA Guerrasio, G Saglio, C Rosso, et al.
Leukemia|June 1, 1994
In vivo clonal evolution of pre-B to B-cell acute lymphoblastic leukemia in childhoodA Toren, G Kende, M Mandel, et al.
Leukemia|June 1, 1994
Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemiaA M Eardley, G Heller, R P Warrell
Leukemia|October 19, 2022
Association of hematologic response and assay sensitivity on the prognostic impact of measurable residual disease in acute myeloid leukemia: a systematic review and meta-analysisNicholas J Short, Chenqi Fu, Donald A Berry, et al.
Leukemia|December 1, 1993
Acute myeloid leukemia (AML) can be oligoclonalH M Schmetzer, H H Gerhartz
Leukemia|March 16, 2002
Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndromeH A Rossi, J O'Donnell, F Sarcinelli, et al.
Leukemia|March 16, 2002
The enhanced in vitro hematopoietic activity of leridistim, a chimeric dual G-CSF and IL-3 receptor agonistA L Abegg, L E Vickery, M E Bremer, et al.
Pageof 963